Furthermore, its expression is down-regulated in more poorly differentiated tumor tissues than that of the differentiated tumor tissues for breast cancer, suggesting the influence of fibulin-2 in breast cancer proliferation and metastasis [103]. This evidence concerns the gene FBLN2 and breast carcinoma.